Position in NTRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$21,058,005
+$6,111,353 QoQ
Shares Held
77,576
+3.8% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#150
of 844 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PARNASSUS INVESTMENTS, LLC holds $1,651,401,789 across 6 Diagnostics & Research names. NTRA ranks #4 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,639,589 | $822,024,341 | |
| 2 | DHR |
Danaher Corp /De/
|
3,674,207 | $699,862,949 | |
| 3 | A |
Agilent Technologies, Inc.
|
607,098 | $80,640,827 | |
| 4 | NTRA |
Natera, Inc.
This page
|
77,576 | $21,058,005 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
29,386 | $15,469,965 | |
| 6 | TWST |
Twist Bioscience Corp
|
120,001 | $12,345,702 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,058,005 | 77,576 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $14,946,652 | 74,737 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,225,986 | 70,828 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,983,948 | 68,236 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $11,766,164 | 69,647 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $8,467,206 | 59,877 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,635,397 | 10,331 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,173,144 | 9,241 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $930,102 | 8,589 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $647,170 | 7,076 | Shares | Sole | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||